- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 41.83M sh |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $22.5M |
| Short Term Debt | Q1 2025 · Mar 31, 2024 | $22.5M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $239.37M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $369.12M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $366.35M |
| Current Liabilities | Q1 2025 · Mar 31, 2024 | $352.44M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $923.03M |
| Total Liabilities | Q1 2025 · Mar 31, 2024 | $996.28M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.18B |
| Current Assets | Q1 2025 · Mar 31, 2024 | $1.33B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.74B |
| Total Assets | Q1 2025 · Mar 31, 2024 | $2.72B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 42.63M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $11.43M |
| Capex | Q1 2025 · Mar 31, 2024 | $39.41M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $7.94M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.73B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.68B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.77 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.78 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $70.19M |
| Net Income | Q1 2025 · Mar 31, 2024 | $75.43M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $96.1M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $244.56M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $286.02M |
| Revenue | Q1 2025 · Mar 31, 2024 | $530.58M |